A systematic review and meta-analysis found no clear advantage for automated red cell exchange. For patients with sickle cell disease (SCD), exchange transfusion has benefits over simple transfusion ...

Sickle cell disease (SCD) is the most common inherited blood disorder in the U.S. It mainly affects African Americans (1 in 500) and Hispanic Americans (1 in 36,000). People with SCD are born with a ...

Dr. Gladwin to Present This Week at Symposium in Brazil, One of 22 Clinical Trial Locations At the Symposium, taking place at HEMORIO, a hematology research and transfusion center in Rio De Janeiro, ...

Recent peer-reviewed study supports what patients shared with their own voices: Automated red blood cell exchange improves the lives of people struggling with sickle cell disease LAKEWOOD, Colo., Nov.

Dr. Richard Lesiyampe(Fourth Left), CEO of Jaramogi Oginga Odinga Teaching and Referral Hospital(JOOTRH) together with fellow staff and medical representatives from The Nairobi West Hospital during ...

Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, has been awarded a three-year Small Business Innovation Research Grant (SBIR) Phase II for a project titled ...

MSK is the first hospital in New York City to offer gene therapy through its pediatric cancer program MSK Kids. Exagamglogene autotemcel (exa-cel) (Casgevy®) is a gene therapy for treating sickle cell ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Cerus Corporation is ...

Regulatory approvals in 14 countries expand treatment options for sickle cell disease, Guillain-Barré syndrome and myasthenia gravis Approvals align with the historic World Health Assembly resolution ...